Panacea Biotek Pharma Ltd.
UkraineAll drugs from this manufacturer
-
The drug is intended for the treatment of adult patients with intermediate-2 and high-risk myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), and acute myeloid leukemia (AML) in certain clinical cases where stem cell transplantation is not possible.
Dosage form: lyophilisate for solution for injection
Active substance Dosage azacitidine 100 mg ATC: L01BC07
-
The drug is prescribed to adults for the treatment of metastatic breast cancer, as well as in combination with other drugs for the treatment of pancreatic adenocarcinoma and non-small cell lung cancer.
Dosage form: powder for infusion
Active substance Dosage paclitaxel 100 mg ATC: L01CD01
-
It is used for the prevention of organ rejection (liver, kidney, or heart) after transplantation, as well as for the treatment of rejection cases that do not respond to other immunosuppressive agents.
Dosage form: capsules, hard
Active substance Dosage tacrolimus 5 mg ATC: L04AD02
-
The drug is used to prevent organ rejection (liver, kidney, or heart) after transplantation, as well as to treat cases of rejection that do not respond to other immunosuppressive agents.
Dosage form: capsules, hard
Active substance Dosage tacrolimus 0.5 mg ATC: L04AD02
-
The drug is used to prevent organ rejection (liver, kidney, or heart) after transplantation, as well as to treat cases of rejection that do not respond to other immunosuppressive agents.
Dosage form: capsules, hard
Active substance Dosage tacrolimus 1 mg ATC: L04AD02